UCSF's Pilot Award supports early-stage research on innovative prevention and treatment strategies for opioid use disorders, emphasizing translational science and real-world impact.
Funder: University of California San Francisco
Due Dates (Anticipated): March 2027 (Full application deadline, Spring cycle only)
Funding Amounts: Up to $40,000 per project for 1 year; direct costs only; not renewable.
Summary: Funds innovative pilot research to advance prevention and treatment of opioid use disorders, supporting preliminary studies that address translational science.
Key Information: Only UCSF faculty, postdocs, and fellows are eligible; residents and specialists are not eligible.
This grant supports innovative pilot projects focused on the prevention and treatment of opioid use disorders. The program is designed to generate preliminary data for future clinical trials or community interventions related to opioid issues, such as pain management, opioid prescribing, and the intersection of pain and addiction. Research domains include clinical, translational, health policy, social science, digital health, and population science, with an emphasis on feasibility studies, secondary data analysis, new methodologies, and early-stage development of therapies or technologies. Projects must address at least one criterion of translational science and may explore implementation strategies in diverse healthcare and community settings, especially those most affected by the opioid crisis. The intent is to foster approaches that can be integrated into health systems and advance the scientific understanding of opioid pharmacology and addiction.